Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07408310

Trial of Spiritual Care Interventions for Patients With Cancer

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
288 (estimated)
Sponsor
Weill Medical College of Cornell University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to determine the effects of 2 spiritual care interventions. Spiritual wellness and healthcare service utilization will be measured from a sample of advanced cancer patients recruited from outpatient settings.

Detailed description

This study is a stratified permuted-block RCT to determine the effects of 2 spiritual care interventions on advanced cancer patients' spiritual wellness (i.e., spiritual well-being and satisfaction of spiritual care needs) and specific forms of healthcare service utilization (i.e., hospice enrollment and ICU admissions) in a sample of advanced cancer patients (N=288) recruited from outpatient settings. Patients will be assigned to "Spiritual Care Intervention #1" (active 1), "Spiritual Care Intervention #2" (active 2), or "Spiritual Care Intervention #3" (control) arm of the trial (overall ratio 1:1:1) using permuted-block randomization within strata defined by geographic location (NYC, Houston Metro Area) and recruitment site (NYC: BMH; Houston Metro Area: UTMB, MDACC). Spiritual care intervention details are being withheld until the trial concludes to protect the scientific integrity of the study. Only 1 of the 2 active interventions will be administered at each site at a given time to avoid within-site cross-contamination between the 2 active intervention arms of the trial.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSpiritual Care Intervention #1Experimental
BEHAVIORALSpiritual Care Intervention #2Experimental
BEHAVIORALSpiritual Care Intervention #3Active Comparator

Timeline

Start date
2026-02-01
Primary completion
2029-04-01
Completion
2029-06-01
First posted
2026-02-13
Last updated
2026-02-13

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT07408310. Inclusion in this directory is not an endorsement.